Bookedited by Michael J.P. Lawman and Patricia D. Lawman.
Contents:
Single Step Antigen Loading and Maturation of Dendritic Cells Through mRNA Electroporation of a Tumor-Associated Antigen and a TriMix of Costimulatory Molecules
Generation of Multiple Peptide Cocktail-Pulsed Dendritic Cells as a Cancer Vaccine
Pulsing Dendritic Cells with Whole Tumor Cell Lysates
Antigen Trapping by Dendritic Cells for Anti-Tumor Therapy
Ex Vivo Loading of Autologous Dendritic Cells with Tumor Antigens
Tumor Antigen/Cytokine-Pulsed Dendritic Cells in Therapy Against Lymphoma
Dendritic Cells Primed with Protein-Protein Fusion Adjuvant
Antigen-Specific mRNA Transfection of Autologous Dendritic Cells
Electroporation of Dendritic Cells with Autologous Total RNA from Tumor Material
Dendritic Cells Transfected with Adenoviral Vectors as Vaccines
Genetic Modification of Dendritic Cells with RNAi
Fast Monocyte-Derived Dendritic Cells-Based Immunotherapy
Intratumoral Injection of BCG-CWS Pretreated Dendritic Cells Following Tumor Cryoablation
Exploiting the CD1d-iNKT Cell Axis for Potentiation of DC-Based Cancer Vaccines
Modification of T Lymphocytes to Express Tumor Antigens
Genetic Modification of Mouse Effector and Helper T Lymphocytes Expressing a Chimeric Antigen Receptor
Genetic Modification of Cytotoxic T Lymphocytes to Express Cytokine Receptors
Monitoring the Frequency and Function of Regulatory T Cells and Summary of the Approaches Currently Used to Inhibit Regulatory T Cells in Cancer Patients
Cytokine Activation of Natural Killer Cells
Loading of Acute Myeloid Leukemia Cells with Poly(I:C) by Electroporation
Autologous Tumor Cells Engineered to Express Bacterial Antigens
Tumor Cell Transformation Using Antisense Oligonucleotide
The Direct Display of Costimulatory Proteins on Tumor Cells as a Means of Vaccination for Cancer Immunotherapy
Cloning Variable Region Genes of Clonal Lymphoma Immunoglobulin for Generating Patient-Specific Idiotype DNA Vaccine
Heat Shock Proteins Purified from Autologous Tumors Using Antibody-Based Affinity Chromatography
Invariant Chain-Peptide Fusion Vaccine Using HER-2/neu
TLR-9 Agonist Immunostimulatory Sequence Adjuvants Linked to Cancer Antigens
Production of Multiple CTL Epitopes from Multiple Tumor-Associated Antigens
Preparation of Polypeptides Comprising Multiple TAA Peptides
Idiotype Vaccine Production Using Hybridoma Technology
Preparation of Cancer-Related Peptide Cocktails that Target Heterogeneously-Expressed Antigens
Making an Avipoxvirus Encoding a Tumor-Associated Antigen and a Costimulatory Molecule
Bacterial Vectors for the Delivery of Tumor Antigens
Preparation of Peptide Microspheres Using Tumor Antigen-Derived Peptides
Production of Antigen-Loaded Biodegradable Nanoparticles and Uptake by Dendritic Cells
Development of Plasmid-Lipid Complexes for Direct Intratumoral Injection
The Use of Dendritic Cells for Peptide-Based Vaccination in Cancer Immunotherapy
Advances in Host and Vector Development for the Production of Plasmid DNA Vaccines
Challenges Facing the Development of Cancer Vaccines
Future of Cancer Vaccines.